New and emerging pharmacologic strategies in the management of chronic heart failure (Q34075359)

30 July 2017

1 reference

title

New and emerging pharmacologic strategies in the management of chronic heart failure (English)

1 reference

30 July 2017

1 reference

chronic heart failure

1 reference

H Krum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

language of work or name

1 reference

1 October 2000

1 reference

30 July 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

page(s)

724-730

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

The evidence for beta blockers in heart failure

15 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Cardiac myocyte necrosis induced by angiotensin II

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Comparison of candesartan, enalapril, and their combination in congestive heart failure: randomized evaluation of strategies for left ventricular dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Short-term oral endothelin-receptor antagonist therapy in conventionally treated patients with symptomatic severe chronic heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Role of endogenous endothelin in chronic heart failure: effect of long-term treatment with an endothelin antagonist on survival, hemodynamics, and cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Role of endothelin in the increased vascular tone of patients with essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Cardiac failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960231008

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

21 January 2018

1 reference

12 December 2020

Tissue expression and immunolocalization of tumor necrosis factor-alpha in postinfarction dysfunctional myocardium

1 reference

12 December 2020

Endotoxin and immune activation in chronic heart failure: a prospective cohort study.

1 reference

12 December 2020

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

12 December 2020

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Plasma endothelin in chronic heart failure

1 reference

12 December 2020

Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group

1 reference

12 December 2020

Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure

1 reference

12 December 2020

Increased concentrations of tumour necrosis factor in "cachectic" patients with severe chronic heart failure

1 reference

12 December 2020

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

12 December 2020

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

1 reference

12 December 2020

Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption

1 reference

12 December 2020

Pressor effects of circulating endothelin are limited by its removal in the pulmonary circulation and by the release of prostacyclin and endothelium-derived relaxing factor

1 reference

12 December 2020

Molecular and functional characterization of the non-isopeptide-selective ETB receptor in endothelial cells. Receptor coupling to nitric oxide synthase

1 reference

12 December 2020

Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failure

1 reference

12 December 2020

Role of endothelin in the exercise intolerance of chronic heart failure

1 reference

12 December 2020

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

12 December 2020

Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines

1 reference

12 December 2020

Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. The SOLVD Investigators.

1 reference

12 December 2020

Aldosterone and antialdosterone therapy in congestive heart failure

1 reference

12 December 2020

Tumour necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

1 reference

12 December 2020

Vasodilator Effects of Endothelin-Converting Enzyme Inhibition and Endothelin ET A Receptor Blockade in Chronic Heart Failure Patients Treated With ACE Inhibitors

1 reference

12 December 2020

Endothelins in the normal and diseased kidney

1 reference

12 December 2020

Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure

1 reference

12 December 2020

Prognostic value of plasma endothelin-1 in patients with chronic heart failure

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators

1 reference

12 December 2020

Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats

1 reference

12 December 2020

Randomised investigation of effects of pentoxifylline on left-ventricular performance in idiopathic dilated cardiomyopathy

1 reference

12 December 2020

1 reference

12 December 2020

Angiotensin II receptor antagonists for heart failure

1 reference

12 December 2020

Endothelin as a regulator of cardiovascular function in health and disease

1 reference

12 December 2020

Endothelin-1 has haemodynamic effects at pathophysiological concentrations in patients with left ventricular dysfunction.

1 reference

12 December 2020

Identifiers

DOI

10.1002/CLC.4960231008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json

15 May 2020

11061049

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6655124&resulttype=core&format=json